Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials
Open Access
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 2 (4) , 689-695
Abstract
No abstract availableKeywords
Funding Information
- ZonMw (836021017, BMBF 01EO1003, 01EO1503)
- Sanquin Blood Supply (2013T083)
- Bristol Myers Squibb Foundation
- Netherlands Heart Foundation (2013T083)
- Bundesministerium für Forschung, Technologie und Raumfahrt (836021017, BMBF 01EO1003, 01EO1503)
This publication has 21 references indexed in Scilit:
- D‐dimer at venous thrombosis diagnosis is associated with risk of recurrenceJournal of Thrombosis and Haemostasis, 2017
- Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management studyBMJ, 2017
- Deep vein thrombosis and pulmonary embolismThe Lancet, 2016
- In vivo reversal of the anticoagulant effect of rivaroxaban with four‐factor prothrombin complex concentrateBritish Journal of Haematology, 2015
- In vivo increase in thrombin generation by four‐factor prothrombin complex concentrate in apixaban‐treated healthy volunteersJournal of Thrombosis and Haemostasis, 2015
- Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: Guidance from the British Committee for Standards in HaematologyBritish Journal of Haematology, 2012
- Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assaysJournal of Thrombosis and Haemostasis, 2011
- Influence of anticoagulant therapy with vitamin K antagonists on plasma levels of coagulation factor VIIIThrombosis Research, 2010
- Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapyCanadian Medical Association Journal, 2008
- Risk of Venous Thromboembolism Recurrence: High Negative Predictive Value of D-dimer Performed after Oral Anticoagulation Is StoppedThrombosis and Haemostasis, 2002